Abstract

Get full access to this article
View all access options for this article.
References
1.
Podell
LB
. Legal implications of preparing and dispensing approved drugs for unlabeled indications . Am J Hosp Pharm
1983 ; 40 : 111 –3 .
2.Investigational use of marketed products . Department of Health and Human Services, Food and Drug Administration , Rockville, MD 20857, Sept 1, 1982 .
